It’s possible that GLP-1s may be useful for a range of substance use disorders, including opioid use disorder and nicotine ...

Achieving Universal Health Coverage (UHC) in Bangladesh remains a challenge due to the high out-of-pocket healthcare costs, particularly for medicines.

U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...

The foundation of patient-focused drug development (PFDD) is to involve patients in the entire drug development process, from clinical trial design to post-market surveillance. While traditional ...

One of the pillars of modern medicine is the life-saving drugs that pharmaceutical companies spend years developing to cure ...

Immunotherapy, which uses programmed immune cells to selectively destroy cancer cells, has transformed cancer treatment.

The late research pioneer Roberta (“Bobbie”) Colman, Willis F. Harrington Professor of Chemistry and Biochemistry at UD, had ...

The grants have been the source of new treatments for cancer, heart disease, diabetes, strokes and H.I.V.; wonder drugs like ...

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

You probably think “antibiotic resistance” means that a bacterial infection can’t be cured by any antibiotics. But the FDA ...